PRGO News

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit

PRGO

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026...

December 6, 2025
Read more →

PRGO ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors

PRGO

NEW YORK--(BUSINESS WIRE)---- $PRGO #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities during the period of February 27, 2023 through November 4, 2025, inclusive (“the Class Period”). If you suffered a loss on your Perrigo investments, you have until January 16, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED

December 5, 2025
Read more →

Levi & Korsinsky Notifies Perrigo Company plc Investors of a Class Action Lawsuit and Upcoming Deadline - PRGO

PRGO

NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Perrigo Company plc ("Perrigo Company plc" or the "Company") (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc...

December 5, 2025
Read more →

PRGO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PRGO

SAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until January 16, 2026 to seek appointment as...

December 3, 2025
Read more →

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit

PRGO

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026...

December 2, 2025
Read more →

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit

PRGO

NEW YORK, Nov. 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class...

November 19, 2025
Read more →

PRGO INVESTOR ALERT: Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead the Perrigo Class Action Lawsuit

PRGO

SAN DIEGO, Nov. 18, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until January 16, 2026 to seek appointment as...

November 18, 2025
Read more →

Rosen Law Firm Urges Perrigo Company plc (NYSE: PRGO) Investors with Large Losses to Contact the Firm for Information About Their Rights

PRGO

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”). Perrigo provides over-the-counter health and wellness solutions. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigatin

November 18, 2025
Read more →

Law Offices of Howard G. Smith Encourages Perrigo Company plc (PRGO) Shareholders to Inquire About Securities Fraud Class Action

PRGO

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Perrigo investors have until January 16, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMI

November 18, 2025
Read more →

Investor Alert: Robbins LLP Informs Investors of the Perrigo Company Plc Class Action

PRGO

SAN DIEGO, Nov. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Perrigo Company plc (NYSE: PRGO) securities between February 27, 2024 and November 4, 2025. Perrigo provides...

November 18, 2025
Read more →

Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference

PRGO

DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Barclays...

Perrigo Widens FY2025 Adj EPS Guidance from $2.90-$3.10 to $2.29-$3.10 vs $2.99 Est; Widens FY2025 Sales Guidance from $4.42B-$4.50B to $4.37B-$4.50B vs $4.44B Est

PRGO

May 7, 2025
Read more →

Perrigo Q1 Adj. EPS $0.60 Beats $0.55 Estimate, Sales $1.04B Miss $1.09B Estimate

PRGO

May 7, 2025
Read more →

Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan

PRGO

JP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026.

April 21, 2025
Read more →

Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027

PRGO

Perrigo Company shares surged after issuing financial targets for 2025 & 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. 'Three-S' plan will enhance cash flow & shareholder return. Q4 results below estimates.

February 28, 2025
Read more →

Perrigo Co Projected FY25-FY27 Organic Net Sales CAGR Of 2.5%-4.5%, Adj EPS CAGR Of High-Single To Low-Double Digit Percentage

PRGO

February 28, 2025
Read more →

Perrigo Co Expects FY25 Sales Growth Of 1%-3% Vs $4.79B Est, Adj EPS Of $2.90-$3.10 Vs $3.36 Est

PRGO

February 28, 2025
Read more →

Perrigo Q4 2024 Adj EPS $0.93 Misses $0.94 Estimate, Sales $1.14B Miss $1.20B Estimate

PRGO

February 27, 2025
Read more →

Perrigo Increases Quarterly Dividend From $0.276 To $0.29 Per Share

PRGO

February 19, 2025
Read more →

Perrigo Reaches $98M Settlement With D&O Insurers To Resolve Coverage Dispute Over 2015-2017 Securities Litigation, Reimbursing Legal And Settlement Costs Before Year-End

PRGO

December 20, 2024
Read more →

Perrigo Now Expects FY24 Organic Net Sales And Reported Net Sales Outlooks Towards Lower End Of Its Previously Stated Ranges

PRGO

November 6, 2024
Read more →

Perrigo Reaffirms FY24 Adjusted EPS Outlook Of $2.50 - $2.65, Est $2.57

PRGO

November 6, 2024
Read more →

Perrigo Q3 2024 Adj EPS $0.81 Misses $0.82 Estimate, Sales $1.09B Miss $1.13B Estimate

PRGO

November 6, 2024
Read more →

Donald J. Trump Posts On Truth I HAVE NEVER, AND WILL NEVER ADVOCATE IMPOSING RESTRICTIONS ON BIRTH CONTROL, or other contraceptives. This is a Democrat fabricated lie, MISINFORMATION/DISINFORMATION, because they have nothing else to run on except FAILURE

PRGO

May 21, 2024
Read more →

Argus Research Upgrades Perrigo to Buy, Announces $46 Price Target

PRGO

September 14, 2022
Read more →

FDA Schedules AdComm Review For First Over The Counter Birth Control Pill

PRGO

September 13, 2022
Read more →

Perrigo Announces Joint FDA Advisory Committee To Review Opill Daily Oral Contraceptive For Over-the-counter Use

PRGO

September 12, 2022
Read more →

Raymond James Maintains Outperform on Perrigo, Lowers Price Target to $48

PRGO

May 4, 2022
Read more →